Milestone Pharmaceuticals Inc.
MIST
$1.07
-$0.06-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.61M | -26.07M | -17.41M | -11.92M | -12.97M |
| Total Depreciation and Amortization | 57.00K | 56.00K | 615.00K | 25.00K | 28.00K |
| Total Amortization of Deferred Charges | 118.00K | 117.00K | 115.00K | 109.00K | 106.00K |
| Total Other Non-Cash Items | 5.94M | 5.30M | 3.84M | 2.11M | 2.15M |
| Change in Net Operating Assets | -215.00K | 4.54M | 63.00K | -69.00K | -1.89M |
| Cash from Operations | -22.71M | -16.05M | -12.78M | -9.75M | -12.57M |
| Capital Expenditure | -26.00K | -45.00K | -283.00K | -2.00K | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.02M | -79.99M | 2.99M | -34.98M | 9.96M |
| Cash from Investing | 111.99M | -80.03M | 2.70M | -34.98M | 9.94M |
| Total Debt Issued | 0.00 | 75.00M | -- | -- | -- |
| Total Debt Repaid | -11.00K | -11.00K | -- | -- | -- |
| Issuance of Common Stock | 9.14M | 19.37M | 36.43M | 46.35M | 36.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 2.57M | -- |
| Cash from Financing | 9.13M | 94.35M | 36.43M | 48.92M | 36.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.41M | -1.73M | 26.36M | 4.19M | -2.59M |